{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:53:07Z","timestamp":1791075187031,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI127070"],"award-info":[{"award-number":["R01AI127070"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EB022563"],"award-info":[{"award-number":["R01EB022563"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL125555"],"award-info":[{"award-number":["R01HL125555"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["DTRACB3947"],"award-info":[{"award-number":["DTRACB3947"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["348774"],"award-info":[{"award-number":["348774"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DoD\/CDMRP Peer Reviewed Cancer Research Program","award":["W81XWH-16-1-0369"],"award-info":[{"award-number":["W81XWH-16-1-0369"]}]},{"DOI":"10.13039\/100014894","name":"Emerald Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014894","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NSF CAREER Award","award":["1553831"],"award-info":[{"award-number":["1553831"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.nano.2018.11.005","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T06:19:01Z","timestamp":1542867541000},"page":"414-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses"],"prefix":"10.1016","volume":"18","author":[{"given":"Joseph D.","family":"Bazzill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina M.","family":"Stronsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Kalinyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz J.","family":"Ochyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse T.","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A.","family":"van Tongeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2018.11.005_bb0005","author":"WHO"},{"key":"10.1016\/j.nano.2018.11.005_bb0010","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JVI.02151-09","article-title":"Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity","volume":"84","author":"Hood","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2018.11.005_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nano.2018.11.005_bb0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol"},{"key":"10.1016\/j.nano.2018.11.005_bb0025","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe","volume":"374","author":"Agnandji","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2018.11.005_bb0030","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1016\/j.vaccine.2017.05.097","article-title":"Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic","volume":"35","author":"Coller","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2018.11.005_bb0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A Recombinant Vesicular Stomatitis Virus Ebola Vaccine","volume":"376","author":"Regules","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2018.11.005_bb0040","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2018.11.005_bb0045","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge","volume":"85","author":"Geisbert","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2018.11.005_bb0050","article-title":"Design of fusion proteins for efficient and soluble production of immunogenic Ebola virus glycoprotein in Escherichia coli","volume":"13","author":"Ji","year":"2018","journal-title":"Biotechnol J"},{"key":"10.1016\/j.nano.2018.11.005_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162446","article-title":"Ebolavirus glycoprotein Fc fusion protein protects guinea pigs against lethal challenge","volume":"11","author":"Konduru","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2018.11.005_bb0060","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.vaccine.2017.01.068","article-title":"Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice","volume":"36","author":"Lehrer","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2018.11.005_bb0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00299-016-2088-6","article-title":"Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells","volume":"36","author":"Rios-Huerta","year":"2017","journal-title":"Plant Cell Rep"},{"key":"10.1016\/j.nano.2018.11.005_bb0070","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1016\/S0264-410X(99)00170-X","article-title":"Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid a","volume":"17","author":"Rao","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2018.11.005_bb0075","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.76.18.9176-9185.2002","article-title":"Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4+ T cells","volume":"76","author":"Rao","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2018.11.005_bb0080","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.vaccine.2016.02.033","article-title":"Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola\/Makona virus glycoprotein (GP) nanoparticle vaccine in mice","volume":"34","author":"Bengtsson","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2018.11.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1403","article-title":"Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens","volume":"9","author":"Fan","year":"2017","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2018.11.005_bb0090","doi-asserted-by":"crossref","first-page":"E4133","DOI":"10.1073\/pnas.1600299113","article-title":"Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose","volume":"113","author":"Chahal","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2018.11.005_bb0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nmat2960","article-title":"Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses","volume":"10","author":"Moon","year":"2011","journal-title":"Nat Mater"},{"key":"10.1016\/j.nano.2018.11.005_bb0100","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1073\/pnas.1112648109","article-title":"Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction","volume":"109","author":"Moon","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2018.11.005_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006516","article-title":"Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination","volume":"5","author":"Li","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nano.2018.11.005_bb0110","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1021\/bc5002246","article-title":"Design of lipid nanocapsule delivery vehicles for multivalent display of recombinant Env trimers in HIV vaccination","volume":"25","author":"Pejawar-Gaddy","year":"2014","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2018.11.005_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12014-016-9119-8","article-title":"Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations","volume":"13","author":"Cazares","year":"2016","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.nano.2018.11.005_bb0120","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nprot.2006.62","article-title":"Blue native PAGE","volume":"1","author":"Wittig","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nano.2018.11.005_bb0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.virol.2010.02.029","article-title":"Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms","volume":"401","author":"Shedlock","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.nano.2018.11.005_bb0130","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nano.2018.11.005_bb0135","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.nano.2011.09.006","article-title":"Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles","volume":"8","author":"Nolte-'t Hoen","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2018.11.005_bb0140","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/nprot.2012.065","article-title":"Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry","volume":"7","author":"van der Vlist","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nano.2018.11.005_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144678","article-title":"Diurnal variations of circulating extracellular vesicles measured by nano flow cytometry","volume":"11","author":"Danielson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2018.11.005_bb0150","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.nano.2015.12.370","article-title":"Enumeration of extracellular vesicles by a new improved flow cytometric method is comparable to fluorescence mode nanoparticle tracking analysis","volume":"12","author":"Pasalic","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2018.11.005_bb0155","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/jth.12602","article-title":"Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing","volume":"12","author":"van der Pol","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.nano.2018.11.005_bb0160","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.celrep.2016.04.078","article-title":"High-density array of well-ordered HIV-1 spikes on synthetic liposomal nanoparticles efficiently activate B cells","volume":"15","author":"Ingale","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.nano.2018.11.005_bb0165","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1128\/JVI.01490-15","article-title":"Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies","volume":"89","author":"Davidson","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2018.11.005_bb0170","doi-asserted-by":"crossref","first-page":"17182","DOI":"10.1073\/pnas.1414164111","article-title":"Structures of protective antibodies reveal sites of vulnerability on Ebola virus","volume":"111","author":"Murin","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2018.11.005_bb0175","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/j.xphs.2016.07.020","article-title":"The density code for the development of a vaccine?","volume":"105","author":"Cheng","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2018.11.005_bb0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/CVI.00425-10","article-title":"Antibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice","volume":"18","author":"Watson","year":"2011","journal-title":"Clin Vaccine Immunol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963418305562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963418305562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:10:22Z","timestamp":1761549022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963418305562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":36,"alternative-id":["S1549963418305562"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2018.11.005","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2018.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}